Nicole Grant

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman et al. · Blood · 2009 · 500 citations · Full text

Medicine, Oncology, Pharmacology +16

Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

Richard F. Little, Stefania Pittaluga, Nicole Grant et al. · Blood · 2003 · 355 citations

Life Sciences, Immunology, Oncology +12

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

Upendra P. Hegde, Armando Filie, Richard F. Little et al. · Blood · 2004 · 353 citations · Full text

Medicine, Hematology, Oncology +12

Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers

Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga et al. · Journal of Clinical Oncology · 2008 · 307 citations · Full text

Medicine, Hematology, Oncology +17

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

Kieron Dunleavy, Richard F. Little, Stefania Pittaluga et al. · Blood · 2010 · 201 citations · Full text

Medicine, Immunology, Oncology +9